Actinobac Biomed Company
Actinobac Biomed focuses on the development of pharmaceutical technologies derived from agents that target LFA-1.
Estimated Revenue:
$1M to $10M
Employee Number:
11-50
Industry:
PharmTech
Headquarters:
North Brunswick, New Jersey, United States
Founded Date:
2009
Technology:
Others